Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis.
Rahil H ShahShyam VedantamShria KumarSunil AminMichelle PearlmanSean BhallaPublished in: Obesity surgery (2023)
Our meta-analysis suggests that IGB therapy is associated with improvements in insulin resistance, blood pressure, and dyslipidemia at 6 months. The results of this analysis suggest that IGB placement can be a viable treatment option to improve important metabolic parameters beyond weight loss alone.
Keyphrases
- blood pressure
- weight loss
- insulin resistance
- systematic review
- bariatric surgery
- metabolic syndrome
- adipose tissue
- type diabetes
- meta analyses
- high fat diet
- hypertensive patients
- polycystic ovary syndrome
- skeletal muscle
- roux en y gastric bypass
- randomized controlled trial
- combination therapy
- high fat diet induced
- blood glucose
- replacement therapy